Enhanced antibacterial effect of the novel T4-like bacteriophage KARL-1 in combination with antibiotics against multi-drug resistant Acinetobacter baumannii

The continuing rise of infections caused by multi-drug resistant bacteria has led to a renewed interest in bacteriophage therapy. Here we characterize phage vB_AbaM-KARL-1 with lytic activity against multi-drug resistant clinical isolates of Acinetobacter baumannii (AB). Besides genomic and phenotyp...

Descripción completa

Detalles Bibliográficos
Autores principales: Jansen, Mathias, Wahida, Adam, Latz, Simone, Krüttgen, Alex, Häfner, Helga, Buhl, Eva Miriam, Ritter, Klaus, Horz, Hans-Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6147977/
https://www.ncbi.nlm.nih.gov/pubmed/30237558
http://dx.doi.org/10.1038/s41598-018-32344-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6147977/
https://www.ncbi.nlm.nih.gov/pubmed/30237558
http://dx.doi.org/10.1038/s41598-018-32344-y

Ejemplares similares